Advertisement

GI & Endoscopy

Exalenz Biosciences, a Jersey City, N.J.-based GI and liver condition diagnostic medical device development company, has announced the global launch of its BreathID Hp.

Advertisement

During the 2013 Digestive Disease Week meeting, Douglas K. Rex, MD, director of endoscopy at Indiana University Hospital and professor of medicine at Indiana University School of Medicine in Indianapolis, presented the findings of a study comparing colon capsule endoscopy…

The FDA has announced that it will not require an investigational new drug application for fecal microbiota as a treatment for C. difficile infections that do not respond to standard treatments, according to report by the American Gastroenterological Association.

Advertisement